Skip to content

Bleichroeder reported holdings

Quarter ended 30 June 2026. Filed with the SEC on 13 August 2026, signed by Andrew Gundlach, Chairman and CEO of Bleichroeder LP. Retrieved 14 October 2026. Page updated 21 October 2026.

Bleichroeder’s reported 13F holdings total $559M across 78 positions as of 30 June 2026. The ten largest make up 77.5% of it, and its value fell 3.4% from the prior quarter.

$559M
Reported 13F value
78
Positions
77.5%
In the 10 largest
−3.4%
Value vs. prior quarter

Largest positions

SPDR Gold TRGOLD SHS$175M
Class
GOLD SHS
Share
31.3%
Gpgi Inc.COM CL A$63M
Class
COM CL A
Share
11.3%
State Str SPDR S&P 500 ETF TTR UNIT$50.5M
Class
TR UNIT
Share
9.0%
Resolute Hldgs Mgmt Inc.COM$45.4M
Class
COM
Share
8.1%
Linde PLCSHS$31.4M
Class
SHS
Share
5.6%
Duos Technologies Group Inc.COM$19.5M
Class
COM
Share
3.5%
Precision Biosciences Inc.COM NEW$15.9M
Class
COM NEW
Share
2.8%
Cue Biopharma Inc.COM$11.7M
Class
COM
Share
2.1%
Blackstone Inc.COM$10.7M
Class
COM
Share
1.9%
Immix Biopharma Inc.COM$10.3M
Class
COM
Share
1.8%
Intellicheck Mobilisa Inc.COM NEW$8.43M
Class
COM NEW
Share
1.5%
S&P Global Inc.COM$8.15M
Class
COM
Share
1.5%
Identiv Inc.COM NEW$7.27M
Class
COM NEW
Share
1.3%
Liqtech Intl Inc.COM$5.84M
Class
COM
Share
1.0%
Kazia Therapeutics LtdSPONSORED ADS$5.63M
Class
SPONSORED ADS
Share
1.0%
Envoy Medical Inc.CL A$4.95M
Class
CL A
Share
0.9%
Cullinan Therapeutics Inc.COM$4.55M
Class
COM
Share
0.8%
Welltower Inc.COM$4.54M
Class
COM
Share
0.8%
Eyepoint Inc.COM NEW$4.53M
Class
COM NEW
Share
0.8%
Fluent Inc.COM NEW$4.26M
Class
COM NEW
Share
0.8%
Genelux CorporationCOM$4.16M
Class
COM
Share
0.7%
Prokidney Corp.SHS CL A$4.08M
Class
SHS CL A
Share
0.7%
Cogent Biosciences Inc.COM$3.87M
Class
COM
Share
0.7%
Invesco Qqq TRUNIT SER 1$3.42M
Class
UNIT SER 1
Share
0.6%
JPMORGAN Chase & COCOM$3.34M
Class
COM
Share
0.6%
Mdxhealth SASHS NEW$3.03M
Class
SHS NEW
Share
0.5%
Opus Genetics Inc.COM$3.03M
Class
COM
Share
0.5%
Grupo Televisa S A BSPON ADR REP ORD$2.79M
Class
SPON ADR REP ORD
Share
0.5%
Barfresh Food Group Inc.COM NEW$2.78M
Class
COM NEW
Share
0.5%
Diamedica Therapeutics Inc.COM NEW$2.69M
Class
COM NEW
Share
0.5%
Rank One Computing Corp.COM SHS$2.64M
Class
COM SHS
Share
0.5%
Spire Global Inc.COM CL A NEW$2.51M
Class
COM CL A NEW
Share
0.4%
Ideal Pwr Inc.COM NEW$2.14M
Class
COM NEW
Share
0.4%
Neuroone Med Technologies COCOM$2.03M
Class
COM
Share
0.4%
Curis Inc.COM$1.99M
Class
COM
Share
0.4%
Revolution Medicines Inc.*W EXP 12/17/202$1.88M
Class
*W EXP 12/17/202
Share
0.3%
Profound Med Corp.COM NEW$1.69M
Class
COM NEW
Share
0.3%
Renovorx Inc.COM NEW$1.63M
Class
COM NEW
Share
0.3%
Modular Med Inc.COM NEW$1.52M
Class
COM NEW
Share
0.3%
Venu Hldg Corp.COM$1.36M
Class
COM
Share
0.2%
Talphera Inc.COM NEW$1.35M
Class
COM NEW
Share
0.2%
QT Imaging Hldgs Inc.COM$1.29M
Class
COM
Share
0.2%
Liberty Live Holdings Inc.COM SHS SER C$1.17M
Class
COM SHS SER C
Share
0.2%
Liberty Defense Hldgs LtdCOM NEW$1.12M
Class
COM NEW
Share
0.2%
Rein Therapeutics Inc.COM NEW$1.04M
Class
COM NEW
Share
0.2%
Owlet Inc.CL A NEW$987K
Class
CL A NEW
Share
0.2%
Sintx Technologies Inc.COM NEW$978K
Class
COM NEW
Share
0.2%
Cellectar Biosciences Inc.COM NEW$803K
Class
COM NEW
Share
0.1%
Maia Biotechnology Inc.COM$720K
Class
COM
Share
0.1%
5e Advanced Materials Inc.COM NEW$638K
Class
COM NEW
Share
0.1%

The share class is shown on a wider screen.

The 50 largest of 78 positions by value, with holdings of the same security combined. The 78 largest are in this firm's machine-readable record. Share counts and quarter-on-quarter changes for each position are on EDGAR. View the full information table on EDGAR

This filing

Form
13F-HR
CIK
1781002
File number
028-20050
Options
0 call, 0 put
In the 25 largest
91.3%
Prior quarter
$579M at 31 March 2026
Positions opened
9
Positions closed
12

Common questions

What are Bleichroeder’s 13F holdings worth?

$559 million across 78 positions for the quarter ended 30 June 2026.

What is Bleichroeder’s largest 13F holding?

SPDR GOLD TR (GOLD SHS) was the largest position at $175 million, or 31.3% of reported 13F value, as of 30 June 2026.

How concentrated is Bleichroeder’s 13F portfolio?

The ten largest positions accounted for 77.5% of reported value and the twenty-five largest for 91.3%, across 78 positions as of 30 June 2026.

Does Form 13F show everything Bleichroeder manages?

No. Form 13F covers only long positions in exchange-traded securities over which the manager has investment discretion, valued at quarter end. It excludes cash, most bonds, private funds, and any assets the firm does not have discretion over, so it is neither the firm's total assets nor any individual client's portfolio.

How often does Bleichroeder file its 13F?

Every quarter. Managers file within 45 days of each quarter's end, so the figures are a snapshot that changes between filings. This page shows the quarter ended 30 June 2026.

Answered from this filing and the prior quarter's.

Back to the Bleichroeder profile

Sources

  1. Form 13F-HR, accession 0001420506-26-001619, filed 13 August 2026 for the quarter ended 30 June 2026.
  2. Form 13F-HR, accession 0001420506-26-001007, filed 14 May 2026 for the quarter ended 31 March 2026.
  3. All 13F filings by this firm on EDGAR.

Retrieved 14 October 2026. Values are as reported by the filer in whole dollars; percentages and quarter-over-quarter figures are arithmetic on the filed tables.

Report a correction

This page restates a public SEC filing for informational purposes only. It is not a recommendation of any security or of Bleichroeder LP, and Niva is not affiliated with the firm. Holdings change; the filing reflects one quarter-end date.